-
Alpha-Synuclein Aggregates as an Inducer of Glial Senescence: Potential Role in Parkinson's Disease
… be a key pathological feature associated with PD, results from the induction of cellular senescence and SASP within … Parkinson’s disease: Findings from these studies will provide important information …
-
IL-13Ra1 and Neuroinflammatory Damage in the MPTP Pre-Clinical Model of PD
… a syndrome clinically and pathologically indistinguishable from PD. We will also carry out a comparative evaluation of … action are already under development. The data collected from the experiments proposed here will help us determine …
-
Running with Attitude
November 2, 2018
… and close friends gave generously. Donations poured in from 20 states and 12 other countries. "Having the Fox … charity event 13 years ago, I wasn't going to get checks from China or Australia." He loves the instant gratification …
-
A Pill to Stop Parkinson's?
November 9, 2018
… Inflazome Ltd., recently announced positive findings from pre-clinical testing of a novel therapy to slow or stop … breakthrough, it can be hard to differentiate information from misinformation. But anyone can be a smart consumer of …
-
MicroRNAs as biomarkers of the prodromal stage of Parkinson disease’
… We have recently reported reduced miRNAs levels in serum from Parkinson disease (PD) patients, and also from patients with idiopathic rapid-eye-movement (REM) sleep …
-
Combining Mass Spectrometry with Genetic and Pharmacological Approaches to Discover and Validate LRRK2 Substrates
… This grant builds upon the research from a prior grant: Combining Mass Spectrometry with Genetic … no reliable laboratory tests for Parkinson's. Data from our study may lead to validation and development of …